Global Eculizumab Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Eculizumab Industry Forecast” looks at past sales and reviews total world Eculizumab sales in 2022, providing a comprehensive analysis by region and market sector of projected Eculizumab sales for 2023 through 2029. With Eculizumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Eculizumab industry.
This Insight Report provides a comprehensive analysis of the global Eculizumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Eculizumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Eculizumab market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Eculizumab and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Eculizumab.
The global Eculizumab market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Eculizumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Eculizumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Eculizumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Eculizumab players cover Alexion. etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Eculizumab market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Eculizumab market?
What factors are driving Eculizumab market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Eculizumab market opportunities vary by end market size?
How does Eculizumab break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Eculizumab Industry Forecast” looks at past sales and reviews total world Eculizumab sales in 2022, providing a comprehensive analysis by region and market sector of projected Eculizumab sales for 2023 through 2029. With Eculizumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Eculizumab industry.
This Insight Report provides a comprehensive analysis of the global Eculizumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Eculizumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Eculizumab market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Eculizumab and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Eculizumab.
The global Eculizumab market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Eculizumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Eculizumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Eculizumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Eculizumab players cover Alexion. etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Eculizumab market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Plasma Exchange
- Plasma Infusion
- PNH
- aHUS
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Alexion
What is the 10-year outlook for the global Eculizumab market?
What factors are driving Eculizumab market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Eculizumab market opportunities vary by end market size?
How does Eculizumab break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Eculizumab Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Eculizumab by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Eculizumab by Country/Region, 2018, 2022 & 2029
2.2 Eculizumab Segment by Type
2.2.1 Plasma Exchange
2.2.2 Plasma Infusion
2.3 Eculizumab Sales by Type
2.3.1 Global Eculizumab Sales Market Share by Type (2018-2023)
2.3.2 Global Eculizumab Revenue and Market Share by Type (2018-2023)
2.3.3 Global Eculizumab Sale Price by Type (2018-2023)
2.4 Eculizumab Segment by Application
2.4.1 PNH
2.4.2 aHUS
2.4.3 Other
2.5 Eculizumab Sales by Application
2.5.1 Global Eculizumab Sale Market Share by Application (2018-2023)
2.5.2 Global Eculizumab Revenue and Market Share by Application (2018-2023)
2.5.3 Global Eculizumab Sale Price by Application (2018-2023)
3 GLOBAL ECULIZUMAB BY COMPANY
3.1 Global Eculizumab Breakdown Data by Company
3.1.1 Global Eculizumab Annual Sales by Company (2018-2023)
3.1.2 Global Eculizumab Sales Market Share by Company (2018-2023)
3.2 Global Eculizumab Annual Revenue by Company (2018-2023)
3.2.1 Global Eculizumab Revenue by Company (2018-2023)
3.2.2 Global Eculizumab Revenue Market Share by Company (2018-2023)
3.3 Global Eculizumab Sale Price by Company
3.4 Key Manufacturers Eculizumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Eculizumab Product Location Distribution
3.4.2 Players Eculizumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ECULIZUMAB BY GEOGRAPHIC REGION
4.1 World Historic Eculizumab Market Size by Geographic Region (2018-2023)
4.1.1 Global Eculizumab Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Eculizumab Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Eculizumab Market Size by Country/Region (2018-2023)
4.2.1 Global Eculizumab Annual Sales by Country/Region (2018-2023)
4.2.2 Global Eculizumab Annual Revenue by Country/Region (2018-2023)
4.3 Americas Eculizumab Sales Growth
4.4 APAC Eculizumab Sales Growth
4.5 Europe Eculizumab Sales Growth
4.6 Middle East & Africa Eculizumab Sales Growth
5 AMERICAS
5.1 Americas Eculizumab Sales by Country
5.1.1 Americas Eculizumab Sales by Country (2018-2023)
5.1.2 Americas Eculizumab Revenue by Country (2018-2023)
5.2 Americas Eculizumab Sales by Type
5.3 Americas Eculizumab Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Eculizumab Sales by Region
6.1.1 APAC Eculizumab Sales by Region (2018-2023)
6.1.2 APAC Eculizumab Revenue by Region (2018-2023)
6.2 APAC Eculizumab Sales by Type
6.3 APAC Eculizumab Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Eculizumab by Country
7.1.1 Europe Eculizumab Sales by Country (2018-2023)
7.1.2 Europe Eculizumab Revenue by Country (2018-2023)
7.2 Europe Eculizumab Sales by Type
7.3 Europe Eculizumab Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Eculizumab by Country
8.1.1 Middle East & Africa Eculizumab Sales by Country (2018-2023)
8.1.2 Middle East & Africa Eculizumab Revenue by Country (2018-2023)
8.2 Middle East & Africa Eculizumab Sales by Type
8.3 Middle East & Africa Eculizumab Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Eculizumab
10.3 Manufacturing Process Analysis of Eculizumab
10.4 Industry Chain Structure of Eculizumab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Eculizumab Distributors
11.3 Eculizumab Customer
12 WORLD FORECAST REVIEW FOR ECULIZUMAB BY GEOGRAPHIC REGION
12.1 Global Eculizumab Market Size Forecast by Region
12.1.1 Global Eculizumab Forecast by Region (2024-2029)
12.1.2 Global Eculizumab Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Eculizumab Forecast by Type
12.7 Global Eculizumab Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Alexion
13.1.1 Alexion Company Information
13.1.2 Alexion Eculizumab Product Portfolios and Specifications
13.1.3 Alexion Eculizumab Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Alexion Main Business Overview
13.1.5 Alexion Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Eculizumab Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Eculizumab by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Eculizumab by Country/Region, 2018, 2022 & 2029
2.2 Eculizumab Segment by Type
2.2.1 Plasma Exchange
2.2.2 Plasma Infusion
2.3 Eculizumab Sales by Type
2.3.1 Global Eculizumab Sales Market Share by Type (2018-2023)
2.3.2 Global Eculizumab Revenue and Market Share by Type (2018-2023)
2.3.3 Global Eculizumab Sale Price by Type (2018-2023)
2.4 Eculizumab Segment by Application
2.4.1 PNH
2.4.2 aHUS
2.4.3 Other
2.5 Eculizumab Sales by Application
2.5.1 Global Eculizumab Sale Market Share by Application (2018-2023)
2.5.2 Global Eculizumab Revenue and Market Share by Application (2018-2023)
2.5.3 Global Eculizumab Sale Price by Application (2018-2023)
3 GLOBAL ECULIZUMAB BY COMPANY
3.1 Global Eculizumab Breakdown Data by Company
3.1.1 Global Eculizumab Annual Sales by Company (2018-2023)
3.1.2 Global Eculizumab Sales Market Share by Company (2018-2023)
3.2 Global Eculizumab Annual Revenue by Company (2018-2023)
3.2.1 Global Eculizumab Revenue by Company (2018-2023)
3.2.2 Global Eculizumab Revenue Market Share by Company (2018-2023)
3.3 Global Eculizumab Sale Price by Company
3.4 Key Manufacturers Eculizumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Eculizumab Product Location Distribution
3.4.2 Players Eculizumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ECULIZUMAB BY GEOGRAPHIC REGION
4.1 World Historic Eculizumab Market Size by Geographic Region (2018-2023)
4.1.1 Global Eculizumab Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Eculizumab Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Eculizumab Market Size by Country/Region (2018-2023)
4.2.1 Global Eculizumab Annual Sales by Country/Region (2018-2023)
4.2.2 Global Eculizumab Annual Revenue by Country/Region (2018-2023)
4.3 Americas Eculizumab Sales Growth
4.4 APAC Eculizumab Sales Growth
4.5 Europe Eculizumab Sales Growth
4.6 Middle East & Africa Eculizumab Sales Growth
5 AMERICAS
5.1 Americas Eculizumab Sales by Country
5.1.1 Americas Eculizumab Sales by Country (2018-2023)
5.1.2 Americas Eculizumab Revenue by Country (2018-2023)
5.2 Americas Eculizumab Sales by Type
5.3 Americas Eculizumab Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Eculizumab Sales by Region
6.1.1 APAC Eculizumab Sales by Region (2018-2023)
6.1.2 APAC Eculizumab Revenue by Region (2018-2023)
6.2 APAC Eculizumab Sales by Type
6.3 APAC Eculizumab Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Eculizumab by Country
7.1.1 Europe Eculizumab Sales by Country (2018-2023)
7.1.2 Europe Eculizumab Revenue by Country (2018-2023)
7.2 Europe Eculizumab Sales by Type
7.3 Europe Eculizumab Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Eculizumab by Country
8.1.1 Middle East & Africa Eculizumab Sales by Country (2018-2023)
8.1.2 Middle East & Africa Eculizumab Revenue by Country (2018-2023)
8.2 Middle East & Africa Eculizumab Sales by Type
8.3 Middle East & Africa Eculizumab Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Eculizumab
10.3 Manufacturing Process Analysis of Eculizumab
10.4 Industry Chain Structure of Eculizumab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Eculizumab Distributors
11.3 Eculizumab Customer
12 WORLD FORECAST REVIEW FOR ECULIZUMAB BY GEOGRAPHIC REGION
12.1 Global Eculizumab Market Size Forecast by Region
12.1.1 Global Eculizumab Forecast by Region (2024-2029)
12.1.2 Global Eculizumab Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Eculizumab Forecast by Type
12.7 Global Eculizumab Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Alexion
13.1.1 Alexion Company Information
13.1.2 Alexion Eculizumab Product Portfolios and Specifications
13.1.3 Alexion Eculizumab Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Alexion Main Business Overview
13.1.5 Alexion Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Eculizumab Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Eculizumab Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Plasma Exchange
Table 4. Major Players of Plasma Infusion
Table 5. Global Eculizumab Sales by Type (2018-2023) & (Kg)
Table 6. Global Eculizumab Sales Market Share by Type (2018-2023)
Table 7. Global Eculizumab Revenue by Type (2018-2023) & ($ million)
Table 8. Global Eculizumab Revenue Market Share by Type (2018-2023)
Table 9. Global Eculizumab Sale Price by Type (2018-2023) & (USD/Kg)
Table 10. Global Eculizumab Sales by Application (2018-2023) & (Kg)
Table 11. Global Eculizumab Sales Market Share by Application (2018-2023)
Table 12. Global Eculizumab Revenue by Application (2018-2023)
Table 13. Global Eculizumab Revenue Market Share by Application (2018-2023)
Table 14. Global Eculizumab Sale Price by Application (2018-2023) & (USD/Kg)
Table 15. Global Eculizumab Sales by Company (2018-2023) & (Kg)
Table 16. Global Eculizumab Sales Market Share by Company (2018-2023)
Table 17. Global Eculizumab Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Eculizumab Revenue Market Share by Company (2018-2023)
Table 19. Global Eculizumab Sale Price by Company (2018-2023) & (USD/Kg)
Table 20. Key Manufacturers Eculizumab Producing Area Distribution and Sales Area
Table 21. Players Eculizumab Products Offered
Table 22. Eculizumab Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Eculizumab Sales by Geographic Region (2018-2023) & (Kg)
Table 26. Global Eculizumab Sales Market Share Geographic Region (2018-2023)
Table 27. Global Eculizumab Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Eculizumab Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Eculizumab Sales by Country/Region (2018-2023) & (Kg)
Table 30. Global Eculizumab Sales Market Share by Country/Region (2018-2023)
Table 31. Global Eculizumab Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Eculizumab Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Eculizumab Sales by Country (2018-2023) & (Kg)
Table 34. Americas Eculizumab Sales Market Share by Country (2018-2023)
Table 35. Americas Eculizumab Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Eculizumab Revenue Market Share by Country (2018-2023)
Table 37. Americas Eculizumab Sales by Type (2018-2023) & (Kg)
Table 38. Americas Eculizumab Sales by Application (2018-2023) & (Kg)
Table 39. APAC Eculizumab Sales by Region (2018-2023) & (Kg)
Table 40. APAC Eculizumab Sales Market Share by Region (2018-2023)
Table 41. APAC Eculizumab Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Eculizumab Revenue Market Share by Region (2018-2023)
Table 43. APAC Eculizumab Sales by Type (2018-2023) & (Kg)
Table 44. APAC Eculizumab Sales by Application (2018-2023) & (Kg)
Table 45. Europe Eculizumab Sales by Country (2018-2023) & (Kg)
Table 46. Europe Eculizumab Sales Market Share by Country (2018-2023)
Table 47. Europe Eculizumab Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Eculizumab Revenue Market Share by Country (2018-2023)
Table 49. Europe Eculizumab Sales by Type (2018-2023) & (Kg)
Table 50. Europe Eculizumab Sales by Application (2018-2023) & (Kg)
Table 51. Middle East & Africa Eculizumab Sales by Country (2018-2023) & (Kg)
Table 52. Middle East & Africa Eculizumab Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Eculizumab Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Eculizumab Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Eculizumab Sales by Type (2018-2023) & (Kg)
Table 56. Middle East & Africa Eculizumab Sales by Application (2018-2023) & (Kg)
Table 57. Key Market Drivers & Growth Opportunities of Eculizumab
Table 58. Key Market Challenges & Risks of Eculizumab
Table 59. Key Industry Trends of Eculizumab
Table 60. Eculizumab Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Eculizumab Distributors List
Table 63. Eculizumab Customer List
Table 64. Global Eculizumab Sales Forecast by Region (2024-2029) & (Kg)
Table 65. Global Eculizumab Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Eculizumab Sales Forecast by Country (2024-2029) & (Kg)
Table 67. Americas Eculizumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Eculizumab Sales Forecast by Region (2024-2029) & (Kg)
Table 69. APAC Eculizumab Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Eculizumab Sales Forecast by Country (2024-2029) & (Kg)
Table 71. Europe Eculizumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Eculizumab Sales Forecast by Country (2024-2029) & (Kg)
Table 73. Middle East & Africa Eculizumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Eculizumab Sales Forecast by Type (2024-2029) & (Kg)
Table 75. Global Eculizumab Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Eculizumab Sales Forecast by Application (2024-2029) & (Kg)
Table 77. Global Eculizumab Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Alexion Basic Information, Eculizumab Manufacturing Base, Sales Area and Its Competitors
Table 79. Alexion Eculizumab Product Portfolios and Specifications
Table 80. Alexion Eculizumab Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 81. Alexion Main Business
Table 82. Alexion Latest Developments
Table 1. Eculizumab Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Eculizumab Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Plasma Exchange
Table 4. Major Players of Plasma Infusion
Table 5. Global Eculizumab Sales by Type (2018-2023) & (Kg)
Table 6. Global Eculizumab Sales Market Share by Type (2018-2023)
Table 7. Global Eculizumab Revenue by Type (2018-2023) & ($ million)
Table 8. Global Eculizumab Revenue Market Share by Type (2018-2023)
Table 9. Global Eculizumab Sale Price by Type (2018-2023) & (USD/Kg)
Table 10. Global Eculizumab Sales by Application (2018-2023) & (Kg)
Table 11. Global Eculizumab Sales Market Share by Application (2018-2023)
Table 12. Global Eculizumab Revenue by Application (2018-2023)
Table 13. Global Eculizumab Revenue Market Share by Application (2018-2023)
Table 14. Global Eculizumab Sale Price by Application (2018-2023) & (USD/Kg)
Table 15. Global Eculizumab Sales by Company (2018-2023) & (Kg)
Table 16. Global Eculizumab Sales Market Share by Company (2018-2023)
Table 17. Global Eculizumab Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Eculizumab Revenue Market Share by Company (2018-2023)
Table 19. Global Eculizumab Sale Price by Company (2018-2023) & (USD/Kg)
Table 20. Key Manufacturers Eculizumab Producing Area Distribution and Sales Area
Table 21. Players Eculizumab Products Offered
Table 22. Eculizumab Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Eculizumab Sales by Geographic Region (2018-2023) & (Kg)
Table 26. Global Eculizumab Sales Market Share Geographic Region (2018-2023)
Table 27. Global Eculizumab Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Eculizumab Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Eculizumab Sales by Country/Region (2018-2023) & (Kg)
Table 30. Global Eculizumab Sales Market Share by Country/Region (2018-2023)
Table 31. Global Eculizumab Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Eculizumab Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Eculizumab Sales by Country (2018-2023) & (Kg)
Table 34. Americas Eculizumab Sales Market Share by Country (2018-2023)
Table 35. Americas Eculizumab Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Eculizumab Revenue Market Share by Country (2018-2023)
Table 37. Americas Eculizumab Sales by Type (2018-2023) & (Kg)
Table 38. Americas Eculizumab Sales by Application (2018-2023) & (Kg)
Table 39. APAC Eculizumab Sales by Region (2018-2023) & (Kg)
Table 40. APAC Eculizumab Sales Market Share by Region (2018-2023)
Table 41. APAC Eculizumab Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Eculizumab Revenue Market Share by Region (2018-2023)
Table 43. APAC Eculizumab Sales by Type (2018-2023) & (Kg)
Table 44. APAC Eculizumab Sales by Application (2018-2023) & (Kg)
Table 45. Europe Eculizumab Sales by Country (2018-2023) & (Kg)
Table 46. Europe Eculizumab Sales Market Share by Country (2018-2023)
Table 47. Europe Eculizumab Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Eculizumab Revenue Market Share by Country (2018-2023)
Table 49. Europe Eculizumab Sales by Type (2018-2023) & (Kg)
Table 50. Europe Eculizumab Sales by Application (2018-2023) & (Kg)
Table 51. Middle East & Africa Eculizumab Sales by Country (2018-2023) & (Kg)
Table 52. Middle East & Africa Eculizumab Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Eculizumab Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Eculizumab Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Eculizumab Sales by Type (2018-2023) & (Kg)
Table 56. Middle East & Africa Eculizumab Sales by Application (2018-2023) & (Kg)
Table 57. Key Market Drivers & Growth Opportunities of Eculizumab
Table 58. Key Market Challenges & Risks of Eculizumab
Table 59. Key Industry Trends of Eculizumab
Table 60. Eculizumab Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Eculizumab Distributors List
Table 63. Eculizumab Customer List
Table 64. Global Eculizumab Sales Forecast by Region (2024-2029) & (Kg)
Table 65. Global Eculizumab Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Eculizumab Sales Forecast by Country (2024-2029) & (Kg)
Table 67. Americas Eculizumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Eculizumab Sales Forecast by Region (2024-2029) & (Kg)
Table 69. APAC Eculizumab Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Eculizumab Sales Forecast by Country (2024-2029) & (Kg)
Table 71. Europe Eculizumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Eculizumab Sales Forecast by Country (2024-2029) & (Kg)
Table 73. Middle East & Africa Eculizumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Eculizumab Sales Forecast by Type (2024-2029) & (Kg)
Table 75. Global Eculizumab Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Eculizumab Sales Forecast by Application (2024-2029) & (Kg)
Table 77. Global Eculizumab Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Alexion Basic Information, Eculizumab Manufacturing Base, Sales Area and Its Competitors
Table 79. Alexion Eculizumab Product Portfolios and Specifications
Table 80. Alexion Eculizumab Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 81. Alexion Main Business
Table 82. Alexion Latest Developments
LIST OF FIGURES
Figure 1. Picture of Eculizumab
Figure 2. Eculizumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Eculizumab Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Eculizumab Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Eculizumab Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Plasma Exchange
Figure 10. Product Picture of Plasma Infusion
Figure 11. Global Eculizumab Sales Market Share by Type in 2022
Figure 12. Global Eculizumab Revenue Market Share by Type (2018-2023)
Figure 13. Eculizumab Consumed in PNH
Figure 14. Global Eculizumab Market: PNH (2018-2023) & (Kg)
Figure 15. Eculizumab Consumed in aHUS
Figure 16. Global Eculizumab Market: aHUS (2018-2023) & (Kg)
Figure 17. Eculizumab Consumed in Other
Figure 18. Global Eculizumab Market: Other (2018-2023) & (Kg)
Figure 19. Global Eculizumab Sales Market Share by Application (2022)
Figure 20. Global Eculizumab Revenue Market Share by Application in 2022
Figure 21. Eculizumab Sales Market by Company in 2022 (Kg)
Figure 22. Global Eculizumab Sales Market Share by Company in 2022
Figure 23. Eculizumab Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Eculizumab Revenue Market Share by Company in 2022
Figure 25. Global Eculizumab Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Eculizumab Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Eculizumab Sales 2018-2023 (Kg)
Figure 28. Americas Eculizumab Revenue 2018-2023 ($ Millions)
Figure 29. APAC Eculizumab Sales 2018-2023 (Kg)
Figure 30. APAC Eculizumab Revenue 2018-2023 ($ Millions)
Figure 31. Europe Eculizumab Sales 2018-2023 (Kg)
Figure 32. Europe Eculizumab Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Eculizumab Sales 2018-2023 (Kg)
Figure 34. Middle East & Africa Eculizumab Revenue 2018-2023 ($ Millions)
Figure 35. Americas Eculizumab Sales Market Share by Country in 2022
Figure 36. Americas Eculizumab Revenue Market Share by Country in 2022
Figure 37. Americas Eculizumab Sales Market Share by Type (2018-2023)
Figure 38. Americas Eculizumab Sales Market Share by Application (2018-2023)
Figure 39. United States Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Eculizumab Sales Market Share by Region in 2022
Figure 44. APAC Eculizumab Revenue Market Share by Regions in 2022
Figure 45. APAC Eculizumab Sales Market Share by Type (2018-2023)
Figure 46. APAC Eculizumab Sales Market Share by Application (2018-2023)
Figure 47. China Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Eculizumab Sales Market Share by Country in 2022
Figure 55. Europe Eculizumab Revenue Market Share by Country in 2022
Figure 56. Europe Eculizumab Sales Market Share by Type (2018-2023)
Figure 57. Europe Eculizumab Sales Market Share by Application (2018-2023)
Figure 58. Germany Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Eculizumab Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Eculizumab Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Eculizumab Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Eculizumab Sales Market Share by Application (2018-2023)
Figure 67. Egypt Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Eculizumab in 2022
Figure 73. Manufacturing Process Analysis of Eculizumab
Figure 74. Industry Chain Structure of Eculizumab
Figure 75. Channels of Distribution
Figure 76. Global Eculizumab Sales Market Forecast by Region (2024-2029)
Figure 77. Global Eculizumab Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Eculizumab Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Eculizumab Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Eculizumab Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Eculizumab Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Eculizumab
Figure 2. Eculizumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Eculizumab Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Eculizumab Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Eculizumab Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Plasma Exchange
Figure 10. Product Picture of Plasma Infusion
Figure 11. Global Eculizumab Sales Market Share by Type in 2022
Figure 12. Global Eculizumab Revenue Market Share by Type (2018-2023)
Figure 13. Eculizumab Consumed in PNH
Figure 14. Global Eculizumab Market: PNH (2018-2023) & (Kg)
Figure 15. Eculizumab Consumed in aHUS
Figure 16. Global Eculizumab Market: aHUS (2018-2023) & (Kg)
Figure 17. Eculizumab Consumed in Other
Figure 18. Global Eculizumab Market: Other (2018-2023) & (Kg)
Figure 19. Global Eculizumab Sales Market Share by Application (2022)
Figure 20. Global Eculizumab Revenue Market Share by Application in 2022
Figure 21. Eculizumab Sales Market by Company in 2022 (Kg)
Figure 22. Global Eculizumab Sales Market Share by Company in 2022
Figure 23. Eculizumab Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Eculizumab Revenue Market Share by Company in 2022
Figure 25. Global Eculizumab Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Eculizumab Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Eculizumab Sales 2018-2023 (Kg)
Figure 28. Americas Eculizumab Revenue 2018-2023 ($ Millions)
Figure 29. APAC Eculizumab Sales 2018-2023 (Kg)
Figure 30. APAC Eculizumab Revenue 2018-2023 ($ Millions)
Figure 31. Europe Eculizumab Sales 2018-2023 (Kg)
Figure 32. Europe Eculizumab Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Eculizumab Sales 2018-2023 (Kg)
Figure 34. Middle East & Africa Eculizumab Revenue 2018-2023 ($ Millions)
Figure 35. Americas Eculizumab Sales Market Share by Country in 2022
Figure 36. Americas Eculizumab Revenue Market Share by Country in 2022
Figure 37. Americas Eculizumab Sales Market Share by Type (2018-2023)
Figure 38. Americas Eculizumab Sales Market Share by Application (2018-2023)
Figure 39. United States Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Eculizumab Sales Market Share by Region in 2022
Figure 44. APAC Eculizumab Revenue Market Share by Regions in 2022
Figure 45. APAC Eculizumab Sales Market Share by Type (2018-2023)
Figure 46. APAC Eculizumab Sales Market Share by Application (2018-2023)
Figure 47. China Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Eculizumab Sales Market Share by Country in 2022
Figure 55. Europe Eculizumab Revenue Market Share by Country in 2022
Figure 56. Europe Eculizumab Sales Market Share by Type (2018-2023)
Figure 57. Europe Eculizumab Sales Market Share by Application (2018-2023)
Figure 58. Germany Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Eculizumab Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Eculizumab Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Eculizumab Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Eculizumab Sales Market Share by Application (2018-2023)
Figure 67. Egypt Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Eculizumab Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Eculizumab in 2022
Figure 73. Manufacturing Process Analysis of Eculizumab
Figure 74. Industry Chain Structure of Eculizumab
Figure 75. Channels of Distribution
Figure 76. Global Eculizumab Sales Market Forecast by Region (2024-2029)
Figure 77. Global Eculizumab Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Eculizumab Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Eculizumab Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Eculizumab Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Eculizumab Revenue Market Share Forecast by Application (2024-2029)
